Lung inflammation and interstitial fibrosis by targeted alveolar epithelial type I cell death

Sandra Carignon,Dorian De Moura Rodrigues,David Gosset,Elodie Culerier,Sarah Huot-Marchand,Florence Savigny,Eric Kaya,Valerie Quesniaux,Aurélie Gombault,Isabelle Couillin,Bernhard Ryffel,Marc Le Bert,Nicolas Riteau
DOI: https://doi.org/10.3389/fimmu.2023.1261483
2023-09-28
Abstract:Introduction: The pathogenesis of chronic lung diseases is multifaceted with a major role of recurrent micro-injuries of the epithelium. While several reports clearly indicated a prominent role for surfactant-producing alveolar epithelial type 2 (AT2) cells, the contribution of gas exchange-permissive alveolar epithelial type 1 (AT1) cells has not been addressed yet. Here, we investigated whether repeated injury of AT1 cells leads to inflammation and interstitial fibrosis. Methods: We chose an inducible model of AT1 cell depletion following local diphtheria toxin (DT) administration using an iDTR flox/flox (idTRfl/fl) X Aquaporin 5CRE (Aqp5CRE) transgenic mouse strain. Results: We investigated repeated doses and intervals of DT to induce cell death of AT1 cells causing inflammation and interstitial fibrosis. We found that repeated DT administrations at 1ng in iDTRfl/fl X Aqp5CRE mice cause AT1 cell death leading to inflammation, increased tissue repair markers and interstitial pulmonary fibrosis. Discussion: Together, we demonstrate that depletion of AT1 cells using repeated injury represents a novel approach to investigate chronic lung inflammatory diseases and to identify new therapeutic targets.
What problem does this paper attempt to address?